Sustained release properties of the once
โ
J. H. G. Jonkman; V. W. Steinijans; W. Beier; W. J. V. Van Der Boon; G. Crasmeij
๐
Article
๐
1989
๐
John Wiley and Sons
๐
English
โ 422 KB
In a multiple dose cross-over experiment in 12 healthy male adults the bioavailability and sustained release characteristics of new once daily BY912 400 mg theophylline capsules (= B, Byk Gulden Research Laboratories, FRG) were studied using Theo-24@ capsules (= T, Searle & Co., USA) as reference.